|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses: | |
| Research and development | |
| Selling, general and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Interest income | |
| Interest expense | |
| Change in fair value of common stock warrant liability | |
| Loss on extinguishment of debt | |
| Other income (expense), net | |
| Loss before provision for income taxes | |
| (Provision for) benefit from income taxes | |
| Net loss | |
| Other comprehensive income (loss): | |
| Foreign currency translation gain (loss) | |
| Unrealized gain on investments, net | |
| Total other comprehensive income (loss) | |
| Total comprehensive loss | |
| Net loss per share attributable to common stockholders, basic | |
| Net loss per share attributable to common stockholders, diluted | |
| Weighted-average shares used to compute net loss per share attributable to common stockholders, basic | |
| Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted | |
| Net loss attributable to common stockholders |
Loading...
